Anticoagulant News and Research

RSS
American Heart Association launches initiative to engage pharmacists in atrial fibrillation care

American Heart Association launches initiative to engage pharmacists in atrial fibrillation care

Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

Study identifies potential strategy to diminish the devastating impacts of traumatic brain injuries

How do acetylsalicylic acid and warfarin interact with various nutrients?

How do acetylsalicylic acid and warfarin interact with various nutrients?

Understanding long COVID: A call for better diagnosis and treatment

Understanding long COVID: A call for better diagnosis and treatment

Study: Most stroke survivors can safely take two types of common antidepressants

Study: Most stroke survivors can safely take two types of common antidepressants

Revolutionary bio-sponge halts bleeding instantly

Revolutionary bio-sponge halts bleeding instantly

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

Common oral anticoagulant rivaroxaban linked to highest risk of bleeding complications

New decision rule can reduce unnecessary head CT scans in older adults after falls

New decision rule can reduce unnecessary head CT scans in older adults after falls

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Initial high-risk antibody profile for antiphospholipid syndrome tends to remain high in pediatric patients, study finds

Initial high-risk antibody profile for antiphospholipid syndrome tends to remain high in pediatric patients, study finds

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Abelacimab significantly reduces bleeding risk in atrial fibrillation patients with stroke risk

Clotting risk from birth control normalizes within weeks of stopping hormonal contraceptives

Clotting risk from birth control normalizes within weeks of stopping hormonal contraceptives

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Decoding long COVID, pathophysiology, epidemiology, diagnosis, and management

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

Mechanical thrombectomy found to be effective for high-risk pulmonary embolism

Atrial fibrillation diagnosis associated with 45% increased risk of mild cognitive impairment

Atrial fibrillation diagnosis associated with 45% increased risk of mild cognitive impairment

New study provides insights into the safety of novel therapies for pulmonary embolism

New study provides insights into the safety of novel therapies for pulmonary embolism

New clinical trial shows simple way to save thousands of units of blood every year

New clinical trial shows simple way to save thousands of units of blood every year

Study confirms accuracy of Vienna Prediction Model for venous thromboembolism

Study confirms accuracy of Vienna Prediction Model for venous thromboembolism

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.